DICE Therapeutics to Participate at Upcoming Investor
SOUTH SAN FRANCISCO, Calif., Feb. 08, 2023 (GLOBE NEWSWIRE) -- DICE Therapeutics, Inc. (Nasdaq: DICE), a
Globe Newswire9-02-2023, 04:09
Aztiq and Innobic Announce Pricing of Secondary Sale of Lotus Common Stock by AEMH 3-07-2023, 08:15